Skip to main content
Essentials of Clinical Psychopharmacology
Featured!

Essentials of Clinical Psychopharmacology, Third Edition

Edited by Alan F. Schatzberg, M.D., and Charles B. Nemeroff, M.D., Ph.D.
2013
899 pages
ISBN 978-1-58562-419-5
Paperback
Item #62419



Essentials of Psychopharmacology provides a synopsis and update of the most clinically relevant material included within its parent publication, The American Psychiatric Publishing Textbook of Psychopharmacology, a classic that has been hailed as indispensable to psychiatry residents and clinicians alike. This new third edition of the Essentials incorporates the latest research and treatment advances and presents key information in an accessible and easy-to-use manner. The chapter authors are among the foremost national authorities in their areas of expertise, and the content has been thoroughly referenced and meticulously edited for maximum utility.

Among the features of this third edition are the following:

  • Commonsense organization that takes the reader through the various classes of psychotropic medications (with chapters focused on individual drugs in each class) to treatment using those drugs (with chapters addressing drug selection and therapeutic approaches to the treatment of patients with major psychiatric disorders).
  • Complete information on each drug’s clinical pharmacology, pharmacokinetics, approved indications, dosages, side effects and toxicology, and drug-drug interactions.
  • Comprehensive coverage of the current psychotropic pharmacopoeia, including new chapters on the recently introduced antipsychotics asenapine, iloperidone, and lurasidone and updated chapters reflecting further accumulation of experience with other medications.
  • Extensive and thoroughly updated information on the use of psychotropic medications during pregnancy and lactation.

Clinicians seeking a reliable reference and guide to the core knowledge base and practice of clinical psychopharmacology can do no better than this new edition of Essentials of Psychopharmacology.

Contributors. Preface. Part I: Classes of Psychiatric Treatments: Animal and Human Pharmacology. Antidepressants and Anxiolytics. Tricyclic and tetracyclic drugs. Fluoxetine. Sertraline. Paroxetine. Fluvoxamine. Citalopram and s-citalopram. Monoamine oxidase inhibitors. Trazodone and nefazodone. Bupropion. Mirtazapine. Venlafaxine and desvenlafaxine. Duloxetine and milnacipran. Benzodiazepines. Buspirone. Antipsychotics. Classic antipsychotic medications. Clozapine. Olanzapine. Quetiapine. Aripiprazole. Risperidone and paliperidone. Ziprasidone. Lurasidone. Asenapine. Iloperidone. Drugs to treat extrapyramidal side effects. Drugs for Treatment of Bipolar Disorder. Lithium. Valproate. Carbamazepine and oxcarbazepine. Gabapentin and pregabalin. Lamotrigine. Topiramate. Other Agents. Cognitive enhancers. Sedative-hypnotics. Psychostimulants and wakefulness-promoting agents. Part II: Psychopharmacological Treatment. Treatment of depression. Treatment of bipolar disorder. Treatment of schizophrenia. Treatment of anxiety disorders. Treatment of substance-related disorders. Treatment of child and adolescent disorders. Psychopharmacology during pregnancy and lactation. Index.

Elias Aboujaoude, M.D.
Donna Ames, M.D.
Jacob S. Ballon, M.D.
Pierre Blier, M.D., Ph.D.
David R. Block, M.D.
Charles L. Bowden, M.D.
Frank W. Brown, M.D.
Mary F. Brunette, M.D.
Peter F. Buckley, M.D.
Matthew Byerly, M.D.
Joseph R. Calabrese, M.D.
Carla M. Canuso, M.D.
Linda L. Carpenter, M.D.
Leslie L. Citrome, M.D., M.P.H.
Anita H. Clayton, M.D.
Yvonne I. Cole, Ph.D.
James W. Cornish, M.D.
Daniella David, M.D.
Jonathan R. T. Davidson, M.D.
Karon Dawkins, M.D.
Charles DeBattista, D.M.H., M.D.
William C. Dement, M.D., Ph.D.
Jamie M. Dupuy, M.D.
Adriana E. Foster, M.D.
Marlene P. Freeman, M.D.
Oliver Freudenreich, M.D.
Mark A. Frye, M.D.
Keming Gao, M.D., Ph.D.
Alan J. Gelenberg, M.D.
Elizabeth H. Gillespie, D.O.
Ira D. Glick, M.D.
Donald C. Goff, M.D.
Robert N. Golden, M.D.
Alan I. Green, M.D.
Philip D. Harvey, Ph.D.
Joseph Henry, M.D.
Michele Hill, M.R.C.Psych.
Ned H. Kalin, M.D.
Paul E. Keck Jr., M.D.
David E. Kemp, M.D., M.S.
Terence A. Ketter, M.D.
Lorrin M. Koran, M.D.
K. Ranga Rama Krishnan, M.D.
Jeffrey A. Lieberman, M.D.
Stephen R. Marder, M.D.
Susan L. McElroy, M.D.
Laura F. McNicholas, M.D., Ph.D.
Emmanuel Mignot, M.D., Ph.D.
Kazuo Mishima, M.D., Ph.D.
Katherine Marshall Moore, M.D.
Henry A. Nasrallah, M.D.
J. Craig Nelson, M.D.
Charles B. Nemeroff, M.D., Ph.D.
John W. Newcomer, M.D.
D. Jeffrey Newport, M.D.
Linda Nicholas, M.D.
Seiji Nishino, M.D., Ph.D.
Sandhaya Norris, M.D.
Charles P. O�Brien, M.D., Ph.D.
Eric D. Peselow, M.D.
Steven R. Pliszka, M.D.
Robert M. Post, M.D.
Michelle M. Primeau, M.D.
B. Ashok Raj, M.D.
Mark Hyman Rapaport, M.D.
Karl Rickels, M.D.
Donald S. Robinson, M.D.
Patrick H. Roseboom, Ph.D.
Jerrold F. Rosenbaum, M.D.
Noriaki Sakai, D.V.M., Ph.D.
Erika F. H. Saunders, M.D.
Alan F. Schatzberg, M.D.
S. Charles Schulz, M.D.
Zafar A. Sharif, M.D.
Jonathan Shaywitz, M.D.
David V. Sheehan, M.D., M.B.A.
George M. Simpson, M.D.
Justin B. Smith, M.D.
Joseph K. Stanilla, M.D.
Zachary N. Stowe, M.D.
Martin T. Strassnig, M.D.
Rajiv Tandon, M.D.
Michael E. Thase, M.D.
Marc L. van der Loos, M.D., Ph.D.
Scott Van Sant, M.D.
Karen Dineen Wagner, M.D., Ph.D.
Po W. Wang, M.D.
Curtis W. Wittmann, M.D.
Joanne D. Wojcik, Ph.D., P.M.H.-C.N.S., B.C.
Tsung-Ung W. Woo, M.D., Ph.D.
Kimberly A. Yonkers, M.D.
Daniel Zigman, M.D.

Alan F. Schatzberg, M.D., is Kenneth T. Norris Jr. Professor of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine in Stanford, California.

Charles B. Nemeroff, M.D., Ph.D., is Leonard M. Miller Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine in Miami, Florida.